Yang H, Zeng X, Liu J, Li J, Li Y, Zhang Q, Shu L, Liu H, Wang X, Liang Y, Hu J, Huang L, Guo Z* and Zhang X*. A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy. J Nanobiotechnol 22, 101 (2024). -北京协和医院 - 协和医院,北京协和医院,協和醫院,北京协和医院首页,北京协和医院电话,协和,協和,医院,醫院,北京協和醫院,北京协和医院妇科,北京协和医院地址,挂号

Yang H, Zeng X, Liu J, Li J, Li Y, Zhang Q, Shu L, Liu H, Wang X, Liang Y, Hu J, Huang L, Guo Z* and Zhang X*. A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy. J Nanobiotechnol 22, 101 (2024).

时间：2024.04.22 发布来源：本站原创

Yang, H., Zeng, X., Liu, J. et al. A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy. J Nanobiotechnol 22, 101 (2024).

https://doi.org/10.1186/s12951-024-02312-y

上一条：Continuously relea...

下一条：Liu H, Sun Y, Li J...